Tempol Protects Cardiomyocytes from Nucleoside Reverse Transcriptase Inhibitor-Induced Mitochondrial Toxicity

類似資料

• Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors
  著者:: Pao, D, 等
  出版事項: (2001)
• Mitochondrial toxicities of nucleoside analogue reverse transcriptase inhibitors in AIDS cases
  著者:: Marfatia, Yogesh S., 等
  出版事項: (2014)
• Progressive Mitochondrial Compromise in Brains and Livers of Primates Exposed In Utero to Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  著者:: Divi, Rao L., 等
  出版事項: (2010)
• Abstracts from the current global literature: Mitochondrial toxicities due to nucleoside reverse transcriptase inhibitors
  著者:: Jain, Sonia, 等
  出版事項: (2012)
• Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors
  著者:: Birkus, Gabriel, 等
  出版事項: (2002)